ARTICLE | Financial News
CAMP4 Therapeutics launches with $30M series A
June 1, 2018 7:31 PM UTC
CAMP4 Therapeutics Corp. (Cambridge, Mass.) launched on May 31 with an untranched $30 million series A round led by new investor Andreessen Horowitz. Existing investors The Kraft Group and Polaris Partners also participated.
A CAMP4 spokesperson told BioCentury that the round will provide 12-18 months of cash...
BCIQ Company Profiles